1.H.E. Mr. Mohammad Talal Al-Nahas (The Chairman of the Board of Director)

2.Eng. Adil Kareem kak Ahmed

3.Dr. Mohammad Khalil Mohammad

4.Mr. Faisal Mohammed Shaker

5. Dr. Fahad Abdulaziz Alrabiah

6. Dr. Mai Abdullah AlAjaji

7.Mr. Khalid Abdulrahman Al-Gwaiz

8. Mr. Abdulrahman Mohammed Al Thinyan

The following Board Member has apologized to attend the meeting:

1- Mr. Ammar Abdulwahid Al-Khudairy

2. Mr. Khaled Abdulrahman Al-Gwaiz (The Chairman of Audit Committee and the Chairman of the Nomination and Remuneration Committee)

3. Mr. Faisal Mohammed Shaker (The Chairman of Governance & Risk Committee)

2. Approve on the Consolidated Financial Statements for the fiscal year ended on 31-12-2021G.

3. Approve on the Auditor’s Report for the fiscal year ended on 31-12-2021G.

4. Approve on releasing the Board of Directors members from liability for the fiscal year ended on 31-12-2021G.

5. Approve on the Board of Directors’ recommendation to distribute cash dividends to the shareholders, for the fiscal year ending 31-12-2021, amounting to SAR 72,000,000 at a rate of SAR (0.60) per share, which represents 6% of the par value of the share. The eligibility of cash dividends will be to the Company’s shareholders who own the Company’s shares by the end of the trading day of the Ordinary General Assembly date, and who are registered in the Company's shareholders registry held with Securities Depository Center Company (Edaa) at the end of the second trading day following the due date. The distribution of dividend will start from 27-06-2022.

6. Approve on delegating the Board of Directors to distribute interim dividends on a biannual or quarterly basis for the fiscal year 2022, and to determine the due date and disbursement in accordance with the Regulatory Rules and Procedures issued pursuant to the Companies Law, in line with the Company's financial position, cash flows, expansion and investment plans.

7. Approve on paying an amount of SAR (4,650,000) as remuneration to the members of the Board of Directors and Committees for the fiscal year ending on December 31, 2021G.

8. Approve on delegating to the Board of Directors the authorization powers of the General Assembly stipulated in paragraph (1) of Article 71 of the Companies Law, for a period of one year starting from the date of the approval by the General Assembly or until the end of the delegated Board of Directors’ term, whichever is earlier, in accordance with the conditions set forth in the Regulatory Rules and Procedures issued pursuant to the Companies Law relating to Listed Joint Stock Companies.

9. Approve on the business and contracts that will be concluded between the Company and Arab Company for Drug Industries and Medical Appliances (ACDIMA), in which the board members Eng. Adel Kareem Ahmed and Dr. Mohammed Khalil Mohammed have an indirect interest, as Eng. Adel Kareem Ahmed is the chairman of ACDIMA, and Dr. Mohammed Khalil Mohammed is the Director General of ACDIMA. The business and contracts are represented in a Share Purchase Agreement between "SPIMACO" and "ACDIMA" for the purchase of shares owned by ACDIMA in CAD Middle East Pharmaceutical Industries, and in the amount of SAR 10,534,356.47, without preferential terms.